Skip to content

Vaborbactam

Vabomere, Vaborem (vaborbactam) is a small molecule pharmaceutical. Vaborbactam was first approved as Vabomere on 2017-08-29. It is used to treat bacterial infections in the USA. It has been approved in Europe to treat bacteremia, bacterial infections, pneumonia, respiratory tract infections, and urinary tract infections amongst others. Vabomere's patents are valid until 2031-08-29 (FDA).
Trade Name Vaborem
Common Name Vaborbactam
Indication bacteremia, bacterial infections, pneumonia, respiratory tract infections, urinary tract infections, ventilator-associated pneumonia
Drug Class Beta-lactamase inhibitors
Vaborbactam
Get full access now